Jose Luis Diez Gil
Overview
Explore the profile of Jose Luis Diez Gil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Novelli L, Sorolla Romero J, Diez Gil J, Amat-Santos I, Brilakis E, Sanz-Sanchez J
JACC Cardiovasc Interv
. 2025 Feb;
PMID: 39985519
No abstract available.
2.
De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Zimbakov Z, et al.
Nutr Metab Cardiovasc Dis
. 2024 Dec;
:103763.
PMID: 39638679
Background And Aim: Diabetes has been shown in last decades to be associated with a significantly higher mortality among patients with ST-segment elevation myocardial infarction (STEMI) treated with primary PCI...
3.
De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira D, Ganyukov V, et al.
J Hypertens
. 2024 Oct;
43(2):246-254.
PMID: 39445586
Background: Hypertension is the most prevalent cardiovascular risk factor, with several detrimental effects on the cardiovascular system. Contrasting results have been reported so far on its prognostic role in patients...
4.
Sorolla Romero J, Teira Calderon A, Vilchez Tschischke J, Diez Gil J, Garcia-Garcia H, Sanz Sanchez J
Rev Esp Cardiol (Engl Ed)
. 2024 Oct;
PMID: 39442793
No abstract available.
5.
Bastante T, Martin-Moreiras J, Alvarez A, Carballo Garrido J, Andraka L, Gomez Jaume A, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
77(11):936-946.
PMID: 39332624
Introduction And Objectives: This article presents the 2023 activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC). Methods: All interventional cardiology laboratories in Spain were...
6.
Tirado-Conte G, Panagides V, Vergara-Uzcategui C, Fernandez G, Vilchez J, Cepas-Guillen P, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
PMID: 39251129
Introduction And Objectives: Thrombocytopenia frequently occurs after transcatheter aortic valve implantation (TAVI) but its impact is poorly understood. We aimed to analyze the incidence, clinical impact, and predictors of acquired...
7.
Cocco M, Campo G, Guiducci V, Casella G, Cavazza C, Cerrato E, et al.
J Am Coll Cardiol
. 2024 Sep;
84(20):2014-2022.
PMID: 39217557
Background: The effectiveness of complete revascularization is well established in patients with ST-segment elevation myocardial infarction (STEMI), but it is less investigated in those with non-ST-segment elevation myocardial infarction (NSTEMI)....
8.
Sanz-Sanchez J, Chiarito M, Gill G, van der Heijden L, Pina Y, Cortese B, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(5):100403.
PMID: 39131458
Small vessel coronary artery disease (CAD) is present in 30% to 67% of patients undergoing percutaneous coronary intervention according to different series, representing an unmet clinical need in light of...
9.
Teira Calderon A, Sans-Rosello J, Fernandez-Peregrina E, Sanz Sanchez J, Bosch-Peligero E, Sanchez-Cena J, et al.
Int J Cardiovasc Imaging
. 2024 Jun;
40(8):1671-1682.
PMID: 38848005
Many lesions in patients undergoing percutaneous coronary intervention (PCI) exhibit significant calcification. Several techniques have been developed to improve outcomes in this setting. However, their impact on coronary microcirculation remains...
10.
Erriquez A, Campo G, Guiducci V, Casella G, Menozzi M, Cerrato E, et al.
JACC Cardiovasc Interv
. 2024 May;
17(12):1425-1436.
PMID: 38752972
Background: The role of quantitative flow ratio (QFR) in the treatment of nonculprit vessels of patients with myocardial infarction (MI) is a topic of ongoing discussion. Objectives: This study aimed...